"On Monday, more than 75 patient groups, including the American Cancer Society Cancer Action Network, the American Lung Association and the Cystic Fibrosis Association, had sent a letter to House leaders saying the bill 'would not increase access to promising therapies' because it didn't deal with the main barriers to experimental drugs — the cost of drugs and company restrictions on making therapies available outside of clinical trials."
I side with the patient disease and care groups here. I think this bill was more or less window-dressing.